mesalamine has been researched along with Intestinal Diseases in 14 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Intestinal Diseases: Pathological processes in any segment of the INTESTINE from DUODENUM to RECTUM.
| Excerpt | Relevance | Reference |
|---|---|---|
| "During the follow-up period, cumulative recurrence rates for intestinal BD were 24." | 1.36 | Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease. ( Cheon, JH; Chung, MJ; Kim, NK; Kim, SU; Kim, TI; Kim, WH; Park, JJ, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, YE | 1 |
| Cheon, JH | 3 |
| Kinoshita, H | 1 |
| Nishioka, H | 1 |
| Ikeda, A | 1 |
| Ikoma, K | 1 |
| Sameshima, Y | 1 |
| Ohi, H | 1 |
| Tatsuno, M | 1 |
| Kouyama, J | 1 |
| Kawamoto, C | 1 |
| Mitsui, T | 1 |
| Tamura, Y | 1 |
| Hashimoto, Y | 1 |
| Nishio, M | 1 |
| Ogashiwa, T | 1 |
| Saigusa, Y | 1 |
| Maeda, S | 1 |
| Kimura, H | 1 |
| Kunisaki, R | 1 |
| Koike, K | 1 |
| Rácz, I | 1 |
| Szalai, M | 1 |
| Kovács, V | 1 |
| Regőczi, H | 1 |
| Kiss, G | 1 |
| Horváth, Z | 1 |
| Fan, S | 1 |
| Li, Y | 1 |
| Pilgrim, S | 1 |
| Velchuru, V | 1 |
| Waters, G | 1 |
| Tsiamis, A | 1 |
| Lal, R | 1 |
| Chung, MJ | 1 |
| Kim, SU | 1 |
| Park, JJ | 1 |
| Kim, TI | 3 |
| Kim, NK | 1 |
| Kim, WH | 3 |
| Jung, YS | 1 |
| Park, SJ | 1 |
| Hong, SP | 1 |
| Choi, CH | 1 |
| Kim, BC | 1 |
| Shin, SJ | 1 |
| Lee, SK | 1 |
| Kim, HS | 1 |
| Donowitz, M | 1 |
| Ahnfelt-Rønne, I | 1 |
| Nielsen, OH | 2 |
| Bukhave, K | 1 |
| Elmgreen, J | 1 |
| Gendre, JP | 1 |
| Loizeau, E | 1 |
| Klotz, U | 1 |
| Rasmussen, SN | 1 |
| Bondesen, S | 1 |
| Binder, V | 1 |
| Hansen, SH | 1 |
| Hvidberg, E | 1 |
2 reviews available for mesalamine and Intestinal Diseases
| Article | Year |
|---|---|
Updated treatment strategies for intestinal Behçet's disease.
Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Gastrointestinal Agents; Human | 2018 |
[New forms of 5-aminosalicylate in inflammatory intestinal lesions].
Topics: Aminosalicylic Acids; Drug Combinations; Glucosamine; Humans; Inflammation; Intestinal Diseases; Mes | 1987 |
1 trial available for mesalamine and Intestinal Diseases
| Article | Year |
|---|---|
Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathy.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Capsule Endoscopy; Female; Humans; Hungary; Intestina | 2013 |
11 other studies available for mesalamine and Intestinal Diseases
| Article | Year |
|---|---|
Remission induction, maintenance, and endoscopic outcome with oral 5-aminosalicylic acid in intestinal Behçet's disease.
Topics: Adolescent; Adult; Aged; Behcet Syndrome; Endoscopy; Female; Humans; Intestinal Diseases; Maintenanc | 2019 |
[Advances in diagnosis and treatment of intestinal Behcet's disease].
Topics: Behcet Syndrome; Colonoscopy; Humans; Immunosuppressive Agents; Intestinal Diseases; Mesalamine | 2015 |
Diaphragm disease and small bowel enteropathy due to nonsteroidal anti-inflammatory drugs: a surgical perspective.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Constriction, Pathologic; Diaphragm; Diclofe | 2011 |
Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behçet disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathiopr | 2010 |
Clinical course of intestinal Behcet's disease during the first five years.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Behcet Syndrome; Disease Pr | 2013 |
Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Fungal; Behcet Syndrom | 2006 |
Arachidonic acid metabolites and their role in inflammatory bowel disease. An update requiring addition of a pathway.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Biological Transport; Bradykinin; Colitis | 1985 |
Sulfasalazine and its anti-inflammatory metabolite, 5-aminosalicylic acid: effect on arachidonic acid metabolism in human neutrophils, and free radical scavenging.
Topics: Aminosalicylic Acids; Arachidonic Acid; Arachidonic Acids; Biphenyl Compounds; Free Radicals; Humans | 1987 |
[Aminosalicylates and chronic inflammatory diseases of the digestive tract].
Topics: Aminosalicylic Acids; Chronic Disease; Humans; Inflammation; Intestinal Diseases; Mesalamine | 1987 |
Clinical efficacy of oral 5-aminosalicylic acid in the treatment of inflammatory bowel disease.
Topics: Administration, Oral; Aminosalicylic Acids; Humans; Inflammation; Intestinal Diseases; Mesalamine | 1985 |
[5-amino-salicylic acid. A review of a new treatment of chronic inflammatory bowel disease].
Topics: Aminosalicylic Acids; Colitis, Ulcerative; Crohn Disease; Humans; Intestinal Diseases; Mesalamine | 1985 |